The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital Bispebjerg and Frederiksberg

About this trial

The goal of this observational study is to explore the potential of implementing a telemedicine-based cross-sector collaboration model to manage patients with frequent admissions with decompensated heart failure. The main question(s) it aims to answer are:

* Characterization of conditions that make these patients vulnerable * Description of key-elements that makes possible to manage the patients with the cardio-share model

Participants are:

* Patients - will be helped to use the available telemedicine tools * General Practitioners - will be offered teleconferences with cardiologists (chat and video) on demand * Community health workers (caregivers at the patient home or in elderly home) - will be guided to assist the patients to use the available telemedicine tools Researchers will compare readmission rates (primary outcome) and quality of life of patients where the cardio-share management model is successfully implemented one year before and after the implementation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

with previous admission with decompensated heart failure in the three-month period prior to the current admission or

who have two or more admissions in the 6 months prior to the current admission.

Disqualifiers

Patients who

have refused to share their data for health-quality projects

have already ongoing telemedicine management for heart failure

Trial population

Patients admitted to the University Hospital of Bispebjerg and Frederiksberg and for whom this is their reference hospital for general heart conditions.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Telemedicine-based cross-sector collaboration for patient management

    Other intervention

    Telemedicine support from the hospital-based cardiology heart-failure team is provided on demand defined by the needs from Primary Care and from the patient rather than plain guideline-based targets

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: cardio-share1 intervention
Group B: Others0 interventions

Trial outcomes

Primary outcomes

1

Days out-of-hospital

Number of days out of hospital from date of discharge for the index event until the next re-admission with acute decompensated heart failure

Time frame
six months

Secondary outcomes

1

Number of readmissions

number of emergency readmissions after discharge from the index readmission, where there have been signs of decompensated heart failure

Time frame
six months
2

Quality of care - Medicines

Proportion of guideline-based target medicines for heart failure that patients actually use (based on purchased medicine prescriptions). This includes angiotensin converter enzyme inhibitors(ACEi)/angiotensin receptor blockers (ARB), Betablockers, Mineralocorticoids, Angiotensin Receptor Neprilysin inhibitors (ARNi), Selective Sodium Glucose Co-Transporter-2 inhibitors (SGLT2i), Hydralazine and Nitrates.

Time frame
six months
3

Symptom-based quality of care

Progression of heart failure specific patient-reported outcome measures. These include weekly to monthly collected: • Out-of-breath in daily activities • Night orthopnea • Dizziness • Feeling body fluid retention (leg swelling, increased abdominal pressure, increased intake of diuretics • Tiredness • Feeling of general worsening

Time frame
six months

Other outcomes

1

Palliative care

Number of subjects with established palliative care

Time frame
six months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.